Memantine and Cozaar drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Memantine (memantine) and Cozaar (losartan potassium). Common drug interactions include general physical health deterioration among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Memantine and Cozaar. It is created by eHealthMe based on reports of 30 people who take the same drugs from the FDA, and is updated regularly.

What is Memantine?

Memantine has active ingredients of memantine. It is often used in alzheimer's disease. eHealthMe is studying from 10,266 Memantine users. Check the latest studies of Memantine.

What is Cozaar?

Cozaar has active ingredients of losartan potassium. It is often used in high blood pressure. eHealthMe is studying from 45,124 Cozaar users. Check the latest studies of Cozaar.

On Jul, 13, 2026

30 people who take Memantine and Cozaar together, and have interactions are studied.

What are the common drug interactions of Memantine and Cozaar, by gender? *:

female:

General physical health deterioration (weak health status)
Haemorrhagic stroke (stroke caused by the rupture of a blood vessel in the brain)
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
Intervertebral disc degeneration (spinal disc degeneration)
Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
Mobility decreased (ability to move is reduced)
Multiple system atrophy (degeneration of nerve cells in specific areas of the brain)
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Neck pain
Neuropathy peripheral (surface nerve damage)

male:

Dyspnoea (difficult or laboured respiration)
Fall
Injection site pruritus (severe itching at injection site)
Injection site reaction
Injection site swelling
Joint injury
Memory impairment
Peripheral swelling
Rash
Sinusitis (inflammation of sinus)

What are the common drug interactions of Memantine and Cozaar, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Dizziness
Dyspnoea (difficult or laboured respiration)
Injection site pain
Injection site pruritus (severe itching at injection site)
Injection site reaction
Injection site swelling
Joint injury
Memory impairment
Peripheral swelling
Rash

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 4 people, 13.33%
Stress And Anxiety: 3 people, 10.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 10.00%
Urticaria (rash of round, red welts on the skin that itch intensely): 2 people, 6.67%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 6.67%
High Blood Cholesterol: 2 people, 6.67%
Hallucinations (sensations that appear real but are created by your mind): 2 people, 6.67%
Essential Hypertension (primary hypertension): 2 people, 6.67%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 2 people, 6.67%
Dyskinesia (abnormality or impairment of voluntary movement): 2 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Memantine and Cozaar?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously